Twitxy Saved

JAMA Health Forum

@JAMAHealthForum

JAMA Health Forum is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.
Chicago, IL jamahealthforum.com Joined January 2011
658 Following 7.8K Followers 9.4K Posts

Latest posts 5

JAMA Health Forum @JAMAHealthForum
馃搳 Some state #Medicaid formularies preferred brand-name drugs over #GenericDrugs when rebates lowered net costs, and these designations were associated with greater brand-name use and potential savings. ja.ma/4Afa7p6
jamanetwork.com State Medicaid Programs' Preference for Brand-Name Over Generic Drugs This cross-sectional study explores the use of the brand-over-generic designation in the state Medicaid program formulary.
JAMA Health Forum @JAMAHealthForum
馃搳 In 4-H Shooting Sports, a #FirearmInjuryPrevention bystander curriculum improved firearm injury risk knowledge over 6 months and produced a small short-term improvement in intention to intervene, with higher perceived behavioral control at 3 months. ja.ma/4ionnlo
jamanetwork.com Firearm Injury Prevention BI for Adolescents in Shooting Sports This cluster randomized clinical trial investigates the effectiveness of a firearm injury prevention bystander intervention (BI) curriculum at 4-H Shooting Sports sites in improving firearm injury...
JAMA Health Forum @JAMAHealthForum
馃摑 Patent settlements between brand-name and generic manufacturers often contained terms that may delay lower-cost generic competition, supporting greater transparency and oversight to protect fair competition and patient access. ja.ma/3VeJx0x
jamanetwork.com Brand-Generic Patent Settlements Reported to the US Federal Trade Commission This case-series study reports on characteristics of brand-name and generic manufacturer patent settlement practices.
JAMA Health Forum @JAMAHealthForum
馃摑 Viewpoint: #OrangeBook patents flagged for delisting can still delay generic competition by remaining listed during ongoing proceedings and preserving 30-month stays, indicating a need for legislative reform to support earlier generic entry. ja.ma/3WSB3N3
jamanetwork.com How Patents Flagged for Delisting Can Still Delay Generic Competition This Viewpoint discusses the legal entanglements that can block generic drug competition on patents flagged for delisting.